Oral neurotherapeutic cefazolin compositions

Details for Australian Patent Application No. 2004268593 (hide)

Owner Revaax Pharmaceuticals, LLC

Inventors Koppel, Gary A.; Chaney, Michael O.

Agent Spruson & Ferguson

Pub. Number AU-B-2004268593

PCT Pub. Number WO2005/020904

Priority 60/497,588 25.08.03 US; 60/533,132 30.12.03 US

Filing date 24 August 2004

Wipo publication date 10 March 2005

Acceptance publication date 2 February 2012

International Classifications

C07D 501/36 (2006.01) Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. cephalosporins

A61K 31/43 (2006.01)

A61K 31/431 (2006.01)

A61K 31/545 (2006.01) - Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula , e.g. cephalosporins, cefaclor, cephalexine

A61K 31/546 (2006.01) - containing further heterocyclic rings, e.g. cephalothin

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

30 March 2006 PCT application entered the National Phase

  PCT publication WO2005/020904 Priority application(s): WO2005/020904

2 February 2012 Application Accepted

  Published as AU-B-2004268593

7 June 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004268594-Beverage compositions comprising monatin and methods of making same

2004268589-Elastic clamp and syringe pump comprising the clamp